Regenerative Medicine for the Treatment of MS | Behind the Bench with Luke Lairson @ScrippsResearch
Regenerative Medicine for the Treatment of MS | Behind the Bench with Luke Lairson  @ScrippsResearch
Uploaded June 2025 | Updated September 2026, 50 minutes ago
Multiple sclerosis (MS) is a debilitating autoimmune disease that disrupts the central nervous system, causing symptoms like muscle weakness, cognitive challenges and a gradual loss of function that current treatments cannot fully repair. MS arises when the immune system attacks the myelin sheath, the protective layer insulating neurons.

Scripps Research chemistry professor Luke Lairson discusses his research on the body’s natural repair pathways—specifically those that activate endogenous stem cells to restore myelin. His work aims to develop therapies that complement existing therapeutic approaches and halt MS progression.

Regenerative medicine for the treatment of MS: Enhancing repair to prevent progression:
https://frontrow.scripps.edu/lectures/regenerative-medicine-for-the-treatment-of-ms-enhancing-repair-to-prevent-progression-luke-lairson-phd/
Regenerative Medicine for the Treatment of MS | Behind the Bench with Luke LairsonFront Row Spotlight | Eric TopolDriving Scientific Discovery | Scripps ResearchScientists identify mutation that could facilitate H5N1 “bird flu” transmission in humansExpanding the drug target universeCan a “switchable” CAR-T reverse autoimmune diseases—without chemotherapy? | Upcoming clinical trialRegenerating tissues to treat diseaseThe John C. Martin Memorial Lectureship | 2026Long COVID research and the many benefits of understanding this disease #shortsHow Donations Empower Future Scientists | The Skaggs Familys ImpactIlluminating Long Covid: Ground Truths Podcast with Ziyad Al-Aly and Eric TopolClass of 2026: The Journey
Scripps Research |

Regenerative Medicine for the Treatment of MS | Behind the Bench with Luke Lairson

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER